Skip to main content
Top

02-05-2024 | Vesicorenal Reflux | Urology – Original Paper

The effect of well-managed lower urinary tract dysfunction on the success rate of endoscopic subureteric injection for low–moderate vesicoureteral reflux

Authors: Cagri Akin Sekerci, Yunus Emre Genc, Mohammad Yasir Sahak, Tufan Tarcan, Selcuk Yucel

Published in: International Urology and Nephrology

Login to get access

Abstract

Aim

We aimed to study the presence of lower urinary tract dysfunction (LUTD) and those objective parameters obtained from voiding diary (VD), uroflowmetric (UF) and postvoiding residual urine (PVR) and voiding dysfunction symptom score (VDSS) as possible factors effecting the success rate on STING to correct VUR.

Materials and methods

Children who underwent STING for the first time due to low–moderate (I–III) grade of VUR were evaluated retrospectively. All children diagnosed with VUR were routinely evaluated for LUTD with VD, UF, PVR and VDSS. Children with LUTD were treated with urotherapy and appropriate medical treatment. Each system with VUR was accepted a renal unit and divided into two groups according to the presence of postoperative VUR: Group 1 no VUR, and Group 2 unresolved VUR. Demographic characteristics, DMSA scintigraphy findings, PVR, VDSS and parameters of VD and UF were compared.

Results

80 children (73 (91.3%) girl, 7 (8.8%) boy) with a total of 112 unit were detected. There were 93 (83%) units in group 1 and 19 (17%) in group 2. No difference was observed in voiding frequency and urinary incontinence in VD, flow pattern, maximum flow rate, MBC/EBC maximum bladder capacity/expected bladder capacity in UF, PVR and VDSS between two groups. 21 (26.25%) children were diagnosed and treated for LUTD and STING was successful in 21 (84%) of 25 units.

Conclusion

We believe that effectively treated preoperative LUTD provides comparable STING success rate for correcting low- to moderate-grade vesicoureteral reflux (VUR) in the short term.
Literature
1.
go back to reference Radmayr C, Bogaert G, Burgu B, Castagnetti MS, Dogan HS, O’Kelly F et al (2023) Vesicoureteral Reflux. EAU Guidelines on Paediatric. Urol 68–76 Radmayr C, Bogaert G, Burgu B, Castagnetti MS, Dogan HS, O’Kelly F et al (2023) Vesicoureteral Reflux. EAU Guidelines on Paediatric. Urol 68–76
2.
go back to reference Baydilli N, Selvi I, Pinarbasi AS, Akinsal EC, Demirturk HC, Tosun H et al (2021) Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux. J Pediatr Urol 17(1):681.e1-e8CrossRef Baydilli N, Selvi I, Pinarbasi AS, Akinsal EC, Demirturk HC, Tosun H et al (2021) Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux. J Pediatr Urol 17(1):681.e1-e8CrossRef
3.
go back to reference Lavelle MT, Conlin MJ, Skoog SJ (2005) Subureteral injection of deflux for correction of reflux: analysis of factors predicting success. Urology 65(3):564–567CrossRefPubMed Lavelle MT, Conlin MJ, Skoog SJ (2005) Subureteral injection of deflux for correction of reflux: analysis of factors predicting success. Urology 65(3):564–567CrossRefPubMed
4.
go back to reference Läckgren G, Sköldenberg E, Stenberg A (2007) Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. J Urol 177(3):1124–1128CrossRefPubMed Läckgren G, Sköldenberg E, Stenberg A (2007) Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. J Urol 177(3):1124–1128CrossRefPubMed
5.
go back to reference Peters CA, Skoog SJ, Arant BS, Copp HL, Elder JS, Hudson RG et al (2017) Management and screening of primary vesicoureteral reflux in children. AUA Guidelines Peters CA, Skoog SJ, Arant BS, Copp HL, Elder JS, Hudson RG et al (2017) Management and screening of primary vesicoureteral reflux in children. AUA Guidelines
7.
go back to reference Sjöström S, Sillén U, Jodal U, Sameby L, Sixt R, Stokland E (2010) Predictive factors for resolution of congenital high grade vesicoureteral reflux in infants: results of univariate and multivariate analyses. J Urol 183(3):1177–1184CrossRefPubMed Sjöström S, Sillén U, Jodal U, Sameby L, Sixt R, Stokland E (2010) Predictive factors for resolution of congenital high grade vesicoureteral reflux in infants: results of univariate and multivariate analyses. J Urol 183(3):1177–1184CrossRefPubMed
8.
go back to reference Van Batavia JP, Ahn JJ, Fast AM, Combs AJ, Glassberg KI (2013) Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction. J Urol 190(4 Suppl):1495–1499CrossRefPubMed Van Batavia JP, Ahn JJ, Fast AM, Combs AJ, Glassberg KI (2013) Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction. J Urol 190(4 Suppl):1495–1499CrossRefPubMed
10.
go back to reference Sillén U, Brandström P, Jodal U, Holmdahl G, Sandin A, Sjöberg I et al (2010) The Swedish reflux trial in children: v bladder dysfunction. J Urol 184(1):298–304CrossRefPubMed Sillén U, Brandström P, Jodal U, Holmdahl G, Sandin A, Sjöberg I et al (2010) The Swedish reflux trial in children: v bladder dysfunction. J Urol 184(1):298–304CrossRefPubMed
11.
go back to reference Chen JJ, Mao W, Homayoon K, Steinhardt GF (2004) A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol 171(5):1907–1910CrossRefPubMed Chen JJ, Mao W, Homayoon K, Steinhardt GF (2004) A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol 171(5):1907–1910CrossRefPubMed
12.
go back to reference Akbal C, Genc Y, Burgu B, Ozden E, Tekgul S (2005) Dysfunctional voiding and incontinence scoring system: quantitative evaluation of incontinence symptoms in pediatric population. J Urol 173(3):969–973CrossRefPubMed Akbal C, Genc Y, Burgu B, Ozden E, Tekgul S (2005) Dysfunctional voiding and incontinence scoring system: quantitative evaluation of incontinence symptoms in pediatric population. J Urol 173(3):969–973CrossRefPubMed
13.
go back to reference Chang SJ, Van Laecke E, Bauer SB, von Gontard A, Bagli D, Bower WF et al (2017) Treatment of daytime urinary incontinence: a standardization document from the International Children’s Continence Society. Neurourol Urodyn 36(1):43–50CrossRefPubMed Chang SJ, Van Laecke E, Bauer SB, von Gontard A, Bagli D, Bower WF et al (2017) Treatment of daytime urinary incontinence: a standardization document from the International Children’s Continence Society. Neurourol Urodyn 36(1):43–50CrossRefPubMed
14.
go back to reference Hjälmås K (1988) Urodynamics in normal infants and children. Scand J Urol Nephrol Suppl 114:20–27PubMed Hjälmås K (1988) Urodynamics in normal infants and children. Scand J Urol Nephrol Suppl 114:20–27PubMed
15.
go back to reference Nakamura M, Moriya K, Mitsui T, Tanaka H, Nonomura K (2009) Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux. J Urol 182(4 Suppl):1694–1697CrossRefPubMed Nakamura M, Moriya K, Mitsui T, Tanaka H, Nonomura K (2009) Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux. J Urol 182(4 Suppl):1694–1697CrossRefPubMed
16.
go back to reference Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P et al (2016) The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn 35(4):471–481CrossRefPubMed Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P et al (2016) The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn 35(4):471–481CrossRefPubMed
17.
go back to reference Yang SS, Chiang IN, Hsieh CH, Chang SJ (2014) The Tzu Chi nomograms for maximum urinary flow rate (Qmax ) in children: comparison with Miskolc nomogram. BJU Int 113(3):492–497CrossRefPubMed Yang SS, Chiang IN, Hsieh CH, Chang SJ (2014) The Tzu Chi nomograms for maximum urinary flow rate (Qmax ) in children: comparison with Miskolc nomogram. BJU Int 113(3):492–497CrossRefPubMed
18.
go back to reference Ural Z, Ulman I, Avanoglu A (2008) Bladder dynamics and vesicoureteral reflux: factors associated with idiopathic lower urinary tract dysfunction in children. J Urol 179(4):1564–1567CrossRefPubMed Ural Z, Ulman I, Avanoglu A (2008) Bladder dynamics and vesicoureteral reflux: factors associated with idiopathic lower urinary tract dysfunction in children. J Urol 179(4):1564–1567CrossRefPubMed
19.
go back to reference Avlan D, Gündoğdu G, Taşkınlar H, Delibaş A, Naycı A (2011) Relationships among vesicoureteric reflux, urinary tract infection and renal injury in children with non-neurogenic lower urinary tract dysfunction. J Pediatr Urol 7(6):612–615CrossRefPubMed Avlan D, Gündoğdu G, Taşkınlar H, Delibaş A, Naycı A (2011) Relationships among vesicoureteric reflux, urinary tract infection and renal injury in children with non-neurogenic lower urinary tract dysfunction. J Pediatr Urol 7(6):612–615CrossRefPubMed
20.
go back to reference Hoebeke P, Van Laecke E, Van Camp C, Raes A, Van De Walle J (2001) One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int 87(6):575–580CrossRefPubMed Hoebeke P, Van Laecke E, Van Camp C, Raes A, Van De Walle J (2001) One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int 87(6):575–580CrossRefPubMed
21.
go back to reference Upadhyay J, Bolduc S, Bagli DJ, McLorie GA, Khoury AE, Farhat W (2003) Use of the dysfunctional voiding symptom score to predict resolution of vesicoureteral reflux in children with voiding dysfunction. J Urol 169(5):1842–1846CrossRefPubMed Upadhyay J, Bolduc S, Bagli DJ, McLorie GA, Khoury AE, Farhat W (2003) Use of the dysfunctional voiding symptom score to predict resolution of vesicoureteral reflux in children with voiding dysfunction. J Urol 169(5):1842–1846CrossRefPubMed
22.
go back to reference Willemsen J, Nijman RJ (2000) Vesicoureteral reflux and videourodynamic studies: results of a prospective study. Urology 55(6):939–943CrossRefPubMed Willemsen J, Nijman RJ (2000) Vesicoureteral reflux and videourodynamic studies: results of a prospective study. Urology 55(6):939–943CrossRefPubMed
23.
go back to reference Van Batavia JP, Nees SN, Fast AM, Combs AJ, Glassberg KI (2014) Outcomes of vesicoureteral reflux in children with non-neurogenic lower urinary tract dysfunction treated with dextranomer/hyaluronic acid copolymer (deflux). J Pediatr Urol 10(3):482–487CrossRefPubMed Van Batavia JP, Nees SN, Fast AM, Combs AJ, Glassberg KI (2014) Outcomes of vesicoureteral reflux in children with non-neurogenic lower urinary tract dysfunction treated with dextranomer/hyaluronic acid copolymer (deflux). J Pediatr Urol 10(3):482–487CrossRefPubMed
Metadata
Title
The effect of well-managed lower urinary tract dysfunction on the success rate of endoscopic subureteric injection for low–moderate vesicoureteral reflux
Authors
Cagri Akin Sekerci
Yunus Emre Genc
Mohammad Yasir Sahak
Tufan Tarcan
Selcuk Yucel
Publication date
02-05-2024
Publisher
Springer Netherlands
Published in
International Urology and Nephrology
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-024-04070-0
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.